Zions Bancorporation National Association UT acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 20,745 shares of the healthcare conglomerate's stock, valued at approximately $10,865,000. UnitedHealth Group comprises approximately 0.7% of Zions Bancorporation National Association UT's investment portfolio, making the stock its 23rd biggest position.
Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter worth about $26,000. Bayforest Capital Ltd raised its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $30,000. IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $42,000. Finally, Kapitalo Investimentos Ltda bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $41,000. Institutional investors own 87.86% of the company's stock.
Insiders Place Their Bets
In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John F. Rex bought 17,175 shares of the stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by company insiders.
UnitedHealth Group Stock Down 0.6%
UnitedHealth Group stock opened at $244.42 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The stock has a market capitalization of $221.72 billion, a PE ratio of 10.59, a price-to-earnings-growth ratio of 1.59 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business has a 50 day simple moving average of $292.78 and a 200-day simple moving average of $408.71.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the business earned $6.80 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.6%. UnitedHealth Group's dividend payout ratio is currently 38.30%.
Analysts Set New Price Targets
Several research analysts have recently commented on the company. Bank of America decreased their price objective on UnitedHealth Group from $350.00 to $300.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 29th. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Mizuho cut their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. Finally, Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $366.52.
Read Our Latest Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report